Orally administered ranitidine plasma concentrations before and after biliopancreatic diversion in morbidly obese patients

Obesity Surgery

Volumn 9, Issue 1, 1999, Pages 36-39

  Cossu, Maria Laura ^a,c   Caccia, Silvio ^b   Coppola, Massimiliano ^a   Fais, Enrico ^a   Ruggiu, Matteo ^a   Fracasso, Claudia ^b   Nacca, Angelo ^b   Noya, Giuseppe ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c NONE   (Italy)

Author keywords

Biliopancreatic diversion; Morbid obesity; Ranitidine plasma concentrations

Indexed keywords

RANITIDINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BILIOPANCREATIC BYPASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HUMAN; MALE; MORBID OBESITY; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROPHYLAXIS; STOMACH ULCER;

EID: 0033024873     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/096089299765553728     Document Type: Article

References (11)

1. 1. Scopinaro N, Gianetta E, Adami GF, et al. Biliopancreatic diversion for obesity at eighteen years. Surgery 1996;119:261-8.
2. 2. Cossu ML, Iannuccelli M; Coppola M, et al. Biliopancreatic diversion in surgical management of morbid obesity: early results in 14 patients. Int J Obes 1996;20(Suppl 4):133.
3. 3. Noya G, Cossu ML, Coppola M, et al. Biliopancreatic diversion for treatment of morbid obesity: experience in 50 cases. Obes Surg 1998;8:61-6.
4. 4. Adami GF, Gandolfo F, Esposito M, et al. Orally administered serum ranitidine concentration after biliopancreatic diversion for obesity. Obes Surg 1991;1:293-4.
5. 5. Hatlebakk JG, Berstad A. Pharmacokinetic optimisation in the treatment of gastro-oesophagel reflux disease. Clin Pharmacokinet 1996;31:386-406.
6. 6. Guiso G, Fracasso C, Caccia S, et al. Determination of ranitidine in rat plasma and brain by high-performance liquid chromatography. J Chromatogr 1987;413:363-9.
7. 7. Van Hecken AM, Tjandramaga TB, Mullie A, et al. Ranitidine: single dose pharmacokinetics and absolute bioavailability in man. Br J Clin Pharmacol 1982;14:195-200.
8. 8. Davis RL, Quenezr RW, Bozigian HP, et al. Pharmacokinetics of ranitidine in morbidly obese women. DICP Ann Pharmacother 1990;24:1040-3.
9. 9. Chau NP, Zech PY, Pozet N, et al. Ranitidine kinetics in normal subjects. Clin Pharmacol Ther 1982;31: 770-4.
10. 10. Gramatté T, Desoky EEL, Klotz, U. Site-dependent small intestinal absorption of ranitidine. Eur J Clin Pharmacol 1994;46:253-9.
11. 11. Peden NR, Richard DA, Saunders JHB. Pharmacologically effective plasma concentration of ranitidine. Lancet 1979;2:199-200.